HIGHLIGHTS
- who: Chenzhe Ma and collaborators from the University of Texas MD Anderson Cancer Center, United States have published the research: Challenges and future of HER2-positive gastric cancer therapy, in the Journal: (JOURNAL)
- future: HER2-targeted CAR-T_cells for treating HER2-positive AGC is a promising therapeutic strategy but additional study is required to determine its toxicity and immunogenicity. HER2 remains an uncertain predictor of gastric cancer prognosis and more research is required .
SUMMARY
Since 2010, China`s cancer incidence and fatality rates have increased, making cancer the leading cause of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.